Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

58.23 -0.96 (-1.63%)
Streaming Delayed Price Updated: 2:23 PM EST, Dec 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
49 50 Next >
3 Beaten-Down Stocks Ready for a Comeback: June 2024
Discover why these beaten-down stocks resurgence despite recent challenges, and explore their fundamentals in healthcare and broadcasting. 
Via InvestorPlace
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. 
Via InvestorPlace
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement. 
Via Investor's Business Daily
Walgreens Plans 'Significant' Store Closures As It Faces 'Difficult Operating Environment'
Major US pharma chain Walgreens to close undisclosed number of stores due to headwinds, CEO acknowledges challenges. Rite Aid also faces bankruptcy. 
Via Benzinga
Behind the Scenes of CVS Health's Latest Options Trends
Via Benzinga
CVS Health's Options Frenzy: What You Need to Know
Via Benzinga
CVS Health Unusual Options Activity For June 05
Via Benzinga
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Stock Of The Day: It's No Coincidence CVS Health Stock Found Support Where It Did
It isn't a coincidence that shares of CVS Health Corporation (CVS) found support where they did. It was at a former resistance level. 
Via Benzinga
Bargain Alert: 7 Long-Term Stocks to Buy Hand-Over-Fist
These seven undervalued stocks across diverse sectors present compelling long-term buying opportunities after significant selloffs. 
Via InvestorPlace
Why Is Moderna Stock Trading Lower On Wednesday?
The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in... 
Via Benzinga
Exposures COVID-19
Investors Worry How Trump Tariffs Could Further Impact Companies Reliant On Chinese Suppliers: Vulnerable Stocks 'Have Underperformed' This Year
Donald Trump proposes replacing income taxes with tariffs on foreign goods, causing skepticism from experts and impacting stocks reliant on Chinese imports. 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
MedImpact's bid to reclaim $200 million after acquiring Rite Aid's pharmacy benefits unit has failed. U.S. Bankruptcy Judge ruled MedImpact assumed Elixir's debts in the $575 million deal. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
US Election And Tariff Prospects Set To Threaten Internationally-Exposed Stocks, Goldman Sachs Warns
Election outcome could impact USD & US firms. Betting odds favor Trump & Republican majority, which may strengthen USD & hurt intl firms. 
Via Benzinga
Topics Government
Exposures Political
Vice President Kamala Harris Courts Corporate Leaders Amidst Tight Biden-Trump Race: Report
Kamala Harris actively courts corporate leaders amidst a competitive Biden-Trump race, seeking to bridge gaps and secure business support through strategic engagements. 
Via Benzinga
3 Must-Buy Stocks for Long-Term Gains: June 2024
Discover why these stocks stand out as compelling must-buy stocks in movies and entertainment, health care services, and pharmacy industries. 
Via InvestorPlace
7 At Risk Dividend Stocks Investors Should Sell Before It’s Too Late
These at-risk dividend stocks could see further price decreases, dividend reductions or both which is why investors should avoid them. 
Via InvestorPlace
Amazon Expands RxPass To Medicare Members: A Closer Look At Savings
Amazon.com Inc. (NASDAQ: AMZN) enhances healthcare accessibility with its RxPass expansion to Medicare beneficiaries, promising an average savings of $70 annually per medication and aiming to reduce... 
Via Benzinga
Bear Of The Day: CVS Health
Since 2018, the amount of lost retail revenue due to theft has grown each year consecutively and soared overall. For example, in 2018, retailers lost about $50 billion to theft. 
Via Talk Markets
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Their prices might not be done falling, but you can count on the dividends they distribute to continue rising steadily. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of CVS Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Maximize Profits with These 3 Discounted Stocks Set to Skyrocket
These discounted stocks are positioned to provide substantial returns to investors given their strong growth potential. 
Via InvestorPlace
Is CVS Health Stock a Millionaire Maker?
The stock's low valuation today could set up investors for oversized gains in the future. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Top 3 Bargain Stocks to Watch Near Their 52-Week Low Prices
Three stocks come to give investors a chance to beat stagflation, analysts think all of these could rise by double-digits in the coming months. 
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy Interest Rates
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance... 
Via Benzinga
How To Earn $500 A Month From CVS Health Stock
CVS Health currently has a dividend yield of 4.38%, which is a quarterly dividend amount of 66.5 cents a share ($2.66 a year). 
Via Benzinga
7 Deeply Discounted Stocks With 100%+ Upside Potential
These deeply discounted stocks in various sectors have compelling turnaround stories and could potentially double or triple in value. 
Via InvestorPlace
Dividend Aristocrats on Sale: 3 Discounted Stocks to Snap Up Now
Bet on these three best discounted dividend aristocrats, known for 25+ years of rising dividends while offering healthy upside. 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
49 50 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.